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Background: In acute myocardial infarction (AMI), both tissue necrosis and edema are present and both might be
implicated in the development of intraventricular dyssynchrony. However, their relative contribution to transient
dyssynchrony is not known. Cardiovascular magnetic resonance (CMR) can detect necrosis and edema with high spatial
resolution and it can quantify dyssynchrony by tagging techniques.
Methods: Patients with a first AMI underwent percutaneous coronary interventions (PCI) of the infarct-related artery
within 24 h of onset of chest pain. Within 5–7 days after the event and at 4 months, CMR was performed. The CMR
protocol included the evaluation of intraventricular dyssynchrony by applying a novel 3D-tagging sequence to the left
ventricle (LV) yielding the CURE index (circumferential uniformity ratio estimate; 1 = complete synchrony). On T2-weighted
images, edema was measured as high-signal (>2 SD above remote tissue) along the LV mid-myocardial circumference
on 3 short-axis images (% of circumference corresponding to the area-at-risk). In analogy, on late-gadolinium
enhancement (LGE) images, necrosis was quantified manually as percentage of LV mid-myocardial circumference on 3
short-axis images. Necrosis was also quantified on LGE images covering the entire LV (expressed as %LV mass). Finally,
salvaged myocardium was calculated as the area-at-risk minus necrosis (expressed as % of LV circumference).
Results: After successful PCI (n= 22, 2 female, mean age: 57± 12y), peak troponin T was 20±36ug/l and the LV ejection
fraction on CMR was 41±8%. Necrosis mass was 30±10% and CURE was 0.91± 0.05. Edema was measured as 58±14%
of the LV circumference. In the acute phase, the extent of edema correlated with dyssynchrony (r2 =−0.63, p< 0.01),
while extent of necrosis showed borderline correlation (r2 =−0.19, p= 0.05). PCI resulted in salvaged myocardium of
27±14%. LV dyssynchrony (=CURE) decreased at 4 months from 0.91±0.05 to 0.94±0.03 (p< 0.004, paired t-test). At
4 months, edema was absent and scar %LV slightly shrunk to 23.7 ± 10.0% (p< 0.002 vs baseline). Regression of LV
dyssynchrony during the 4 months follow-up period was predicted by both, the extent of edema and its necrosis
component in the acute phase.
Conclusions: In the acute phase of infarction, LV dyssynchrony is closely related to the extent of edema, while necrosis is
a poor predictor of acute LV dyssynchrony. Conversely, regression of intraventricular LV dyssynchrony during infarct
healing is predicted by the extent of necrosis in the acute phase.
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Myocardial infarction (MI) causes formation of scar tissue
and impairment of regional and global left ventricular
(LV) function [1,2]. Typical characteristics of the altered
motion pattern are reduced LV contraction [3,4] and post-
systolic shortening in infarcted regions [5-7]. The assess-
ment of LV dyssynchrony, which is a common finding in
patients with MI [8], serves as a predictor for LV remode-
ling [9]. Therefore, measurement of mechanical LV func-
tion is an important factor to determine long-term
prognosis and optimal treatment after MI.
Furthermore, assessment of LV regional contraction and
dyssynchrony can give valuable insight with regard to car-
diac resynchronization therapy (CRT) [10,11]. To date,
CRT has proven successful in large patient populations as
an adjunctive therapy for patients with drug-refractory
heart failure and ventricular conduction delay. However,
approximately 30% of these patients do not appear to bene-
fit from CRT when applying current criteria (symptoms,
LV-EF, and ECG findings) for CRT patient selection [10]. A
modality that assesses regional LV mechanical function ra-
ther than LV electrical conduction fast and accurately could
have great potential to improve patient selection for CRT
[12]. Response rate for CRT has been reported to be lower
in ischemic cardiomyopathy versus cardiomyopathies of
other origin [13]. This could be related to the fact, that
post-ischemic cardiomyopathy is likely to represent a dy-
namic process e.g. during infarct healing. However, little
data exist on the development of dyssynchrony during
post-infarction remodeling, and in particular, the influence
of acute edema and necrosis on dyssynchrony is not
known. Therefore, this study was undertaken to explore the
evolution of dyssynchrony in relation to edema and necro-
sis/scar development after AMI and thus, to enhance our
understanding of these processes to better evaluate in the
future post-MI patients for CRT.
Cardiovascular magnetic resonance (CMR) with myo-
cardial tagging [14] is a powerful method to assess
deformation of the myocardium non-invasively. Three-
dimensional (3D) tagging was introduced to allow the
acquisition of complete 3D motion information covering
the entire LV in only three breath-holds [15,16]. The
method showed already comprehensive dyssynchrony
quantification and high reproducibility in patients with left
bundle branch block and acute MI [1]. In the current study,
the 3D tagging method was used to measure LV contrac-
tion and dyssynchrony in patients after acute MI and at
four months post-MI. It was reported in several previous
studies that the amounts of scar tissue and healthy myocar-
dium, as measured by late-gadolinium enhancement (LGE)
imaging, correlate with important global LV function para-
meters such as ejection fraction and LV volumes [17,18].
Furthermore, it could be shown that the amount of LGE
diminishes in MI patients from the acute to the chronicstate [17,19]. CMR is also able to detect and quantify myo-
cardial edema [20]. Therefore, in this study we used CMR
to investigate changes in LV contraction and LV dyssyn-
chrony in patients during the first four months after an
acute MI. Specifically, it was hypothesized that both, necro-
sis and the size of the edema on T2-weighted images are
responsible for dyssynchronic contractions of the LV in the
acute phase. Secondly, the study was designed to investigate
the influence of edema and necrosis in the acute phase on
changes of LV dyssynchrony during infarct healing.
Methods
Study population
The study protocol was approved by the local Ethics
Committee and all subjects gave written informed con-
sent before study participation. Between November 2006
and August 2010, 22 patients (20 male/2 female,
age = 56.9 ± 12.4 years) were examined at baseline
7.5 ± 4.1 days after first anterior MI and again at follow-
up 4 months later (120.8 ± 21 days after MI). Ten
patients participated in a previously published study [1].
Exclusion criteria for study participation were contrain-
dications to CMR (typically incompatible metallic
implants, claustrophobia). All recruited patients com-
pleted the study and no patients were lost to follow-up.
Detailed characteristics and medications of all patients
are given in Table 1, respectively.
Data acquisition
All measurements were performed on a 1.5 T MRI scan-
ner (Achieva, Philips Healthcare, Best, The Netherlands).
All acquisitions were performed during end-inspiration
breath-hold periods. After acquiring survey images and
reference data for sensitivity encoding (SENSE) [21] LV
short-axis and long-axis images were acquired in order to
plan subsequent scans. To assess global LV function, short-
axis images covering the entire LV were then acquired in
all patients using a steady state fee precession (SSFP)
sequence (cardiac phases =25, temporal resolution=45 ms,
slice thickness= 8 mm, 13–16 contiguous slices).
For the 3D tagging data acquisition an accelerated ac-
quisition scheme was applied [1,16]. Imaging parameters
were as follows: FOV= 108x108x108 mm3, matrix size =
28x14x16, receiver bandwidth = 220 Hz/pixel, number of
profiles per EPI-segment = 7, number of excitations per
heart phase = 4, echo time = 3.3 ms.
Edema imaging was performed with a standard T2-
weighted (T2w) double-inversion black-blood spin-echo
sequence (FOV=350×350 mm2, pixel size=1.4× 1.4 mm2,
repetition time=2 R to R intervals, echo time=100 ms,
slice thickness= 8 mm) in 3 short-axis slices (basal, midven-
tricular, and apical).
LGE short-axis images were acquired in all patients 15
minutes after administration of a bolus of 0.25 mmol/kg
Table 1 Patient Characteristics and Medications
Baseline (n=22) Follow-up (n=22)
Gender, n (%)
Male 20 (91%)
Female 2 (9%)
Age [years] 56.9 (±12.4)
Body mass index [kg/m2] 29.0 (±5.8)
Risk factors, n [%]
Diabetes mellitus 11 (50%)
Hypertension 12 (55%)
Hyperlipidemia 9 (41%)
Family history of CAD 5 (23%)
Current smoker 7 (32%)
History, n [%]
Previous coronary angioplasty 0 (0%)
Previous MI 0 (0%)
Cardiac biomarkers
Peak CK [U/l] 4113.6 (±2339.7)
Peak CK MB [U/l] 432.1 (±413.7)
Peak Troponin T [μg/l] 20.3 (±35.7)
Coronary artery disease
Number of obstructed vessels
Infarct related vessel†, n [%]
LAD 22 (100%)
RCX 0 (0%)
RCA 0 (0%)
Acute coronary syndroms, n [%]
STEMI 22 (100%)
Medications, n [%]
Aspirin 2 (9%) 22 (100%)
Beta-blocker 0 (0%) 15 (68%)
ACE inhibitor 1 (5%) 18 (82%)
Statin 0 (0%) 22 (100%)
Calcium channel blocker 0 (0%) 0 (0%)
Sartane 0 (0%) 5 (23%)
Diuretic 0 (0%) 3 (14%)
Clopidogrel 0 (0%) 22 (100%)
Oral anticoagulant 0 (0%) 2 (9%)
Demographic characteristics, cardiac risk factors, history, cardiac biomarkers
and coronary artery disease characteristics of all patients (n=22) included in
the analysis are given.
MI = myocardial infarction; CAD = coronary artery disease; CK = creatine
kinase; CK MB = creatine kinase isonenzyme MB; LAD = left anterior
descending coronary artery; RCX = right circumflex coronary artery; RCA =
right coronary artery; STEMI = ST-segment elevation myocardial infarction;
NSTEMI = non ST-segment elevation myocardial infarction. A significant
coronary stenosis was defined as ≥50% stenosis (percent luminar diameter
narrowing). All data collected during the first examination. †Based on core
laboratory analysis of the X-ray coronary angiograms. Medications of all
patients with acute myocardial infarction (n=22) are listed for time of
admission and at the time of follow-up. ACE = angiotensin-converting enzyme.
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Pharma, Germany). An inversion recovery segmented gra-
dient echo sequence was employed with an inversion time
set to null normal myocardium (FOV=350×350 mm2,
pixel size=1.5× 1.5 mm2, repetition time=7.4 ms, echo
time=4.4 ms, slice thickness= 8 mm, no slice gap). All MR
data, and specifically the T2-weighted and LGE data, were
acquired using a cardiac surface coil.
Data analysis
The 3D tagging data were post-processed with HARP [22]
using an extended software tool originally designed for the
analysis of two-dimensional tagging data (TagTrack,
GyroTools Ltd., Zurich, Switzerland). Eight to eleven short-
axis midwall contours, consisting of multiple landmark
points arranged in steps of about 5˚, were defined on diffe-
rent slices between base and apex. Midwall circumferential
shortening (csh in %) was defined as the length change of a
contour relative to the original length at end-diastole (first
heart phase). For a detailed analysis of csh in 48–66
segments of each LV, each midwall contour was divided
into sectors of 60˚ starting at the anterior epicardial junc-
tion of the right and the left ventricle on the equatorial level
and numbered consecutively from S1 to S6 in clockwise
direction as viewed from the apex. The time to maximum
csh (Tmax) was automatically determined for each segment.
Segments in which Tmax was detected in the first three or
in the last acquired time frame where inspected by an
observer and corrected manually if necessary. As a measure
for mechanical LV dyssynchrony the coefficient of va-
riation in csh (CVcsh in %) at end-systole, as well as the
circumferential uniformity ratio estimate (CURE)-index
were calculated [23,24]. CURE ranged from 0 (pure dys-
synchrony) to 1 (synchronous). End-systole was defined in
all patients as the moment of aortic valve closure assessed
from SSFP images.
Data sets were post-processed using an in-house soft-
ware (GTVolume, GyroTools Ltd., Zurich, Switzerland).
For calculations of LV volumes and ejection fraction,
endo- and epicardial borders were delineated manually
on all acquired SSFP slices. On T2-weighted images,
edema was measured as high-signal (>2 SD above re-
mote tissue) along the LV mid-myocardial circumference
on 3 short-axis images distributed equally along the LV
long axis and was expressed as percentage of LV circum-
ference. This evaluation along the LV mid-myocardial
centreline was chosen to avoid the subendocardial re-
gion where tissue signals can be difficult to distinguish
from signal of stagnant blood of the LV cavity. In ana-
logy, on LGE images, necrosis was quantified manually
as percentage of LV mid-myocardial circumference on 3
short-axis images. For this analysis 3 short-axis LGE
images were selected from the stack of LGE images
according anatomical landmarks that matched those of
Manka et al. Journal of Cardiovascular Magnetic Resonance 2012, 14:47 Page 4 of 10
http://www.jcmr-online.com/content/14/1/47the T2-weighted images. The salvaged myocardium was
calculated as area-at-risk (%LV circumference) minus
necrosis (%LV circumference) and is expressed as %LV
circumference (Figure 1). The total amount of necrosis
and fibrosis was also quantified on LGE images covering
the entire LV by summing of LGE tissue of all LV slices
(expressed as %LV mass) in the acute and follow-up
studies at 4 months.Statistics
Statistical analysis was performed by using the SPSS
software package release 15.0.1 (Chicago, IL, USA) and
MedCalc (Mariakerke, Belgium). Mean values+ SD were
calculated for all groups. The paired Student’s t-test or
Wilcoxon test and independent samples t-test or
Mann–Whitney test were used to test for differences
within and between groups. All tests were two-tailed.
The Kolmogorov–Smirnov test was used to test for
normality. P-values less than 0.05 were consideredFigure 1 Patient example (A) shows acute myocardial infarction (MI)
edema in the anterior/anteroseptal segments on T2-weighted (T2) im
(grey arrows = inferior junction of the right ventricle (RV) with the in
postion). (D) represents circumferential signal intensities on late gadoliniumstatistically significant. The study was powered for the
CURE index determined by 3D tagging CMR. A previ-
ous study [1] yielded a difference in CURE of 0.08 be-
tween controls and patients with old MIs assessed by
CMR. Assuming that in the acute phase edema would de-
crease CURE by another 50% of this difference (= expected
difference of 0.04 in CURE in the acute vs chronic MI), and
considering a SD of 0.03 (intra-observer difference in (1)
for CURE), a sample size of n=18 (α=0.05; power 80%)
would be needed. A larger patient group was recruited to
account for possible dropouts and a potentially smaller
difference of the CURE index at 4 month follow-up, which
was not known a priori.Results
Table 1 summarizes patient characteristics and medica-
tion. The mean age was 57 years and the majority of
patients were male. All patients had an acute ST-
segment elevation MI which was treated by PCI. Theon late gadolinium enhancement images and (B) corresponding
ages and (C) shows corresponding 3D tagging at endsystole
terventricular septum represents the beginning of circumferential
enhancement images and (E) on T2-weighted images.
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coronary artery in all patients.
Predictor of LV dyssynchrony in the acute phase of MI:
Figure 2 shows that in the acute phase of MI the
circumferential extent of edema strongly correlated with0.78
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Figure 2 Predictors of LV dyssynchrony in the acute phase of MI.dyssynchrony (Figure 2a, r2 = 0.63, p< 0.0001), while the
circumferential extent of necrosis showed borderline
correlation only (Figure 2b, r2 = 0.19, p= 0.05) as did the
circumferential extent of salvaged myocardium (Figure 2c,
r2 = 0.165, p=0.06). Necrosis mass (Figure 2d, r2 = 0.02,0.78
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Figure 3 Change of LV dyssynchrony at 4 months post-acute
MI. Lines track individual patient values at baseline to follow-up.
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p=0.4) did not correlate with dyssynchrony in the acute
phase of MI.
Predictors of LV remodelling and LV dyssynchrony
during healing of MI
A 4 months follow-up was available for all patients. The
main study results are compiled in Table 2. Both, LVEDV
and LVESV slightly increased, while LV ejection did not
change significantly. LV scar shrunk slightly from 29.6% to
23.7% of LV mass at 4 months. When using LVEDV/
LVmass as a measure of LV remodelling, an increase of this
index occurred during the follow-up period (Table 2). At
4 months post-acute MI, intraventricular LV dyssynchrony
was significantly reduced vs baseline (Figure 3; p= 0.004).
In the 22 patients, no LV edema was detected at 4 months
(see example in Figure 4).
Best predictor for regression of LV dyssynchrony during
the 4 months follow-up period (expressed as ΔCURE) was
the extent of edema in the acute phase (Figure 5 a). This
correlation with edema extent was explained by its necrosis
component (=extent of necrosis) which also correlated with
regression of dyssynchrony (Figure 5b), while the portion of
viable tissue in the edema territory (= salvaged myocar-
dium) did not correlate with the regression of dyssynchronyTable 2 Study results
Baseline
(n=22)
Follow-up
(n=22)
P-value
Days after AMI 7.5±4.1 120.8±20.6 -
Heart rate (bpm) 76±18 68±6 0.006
LVEDD [mm] 51.0±7.7 54.9±7.6 0.0005
LVEDV [ml] 156.8±50.5 177.9±66.4 0.01
LVESV [ml] 96.7±39.2 113.0±50.8 0.005
LVEF [%] 40.5±8.2 38.5±8.6 Ns
LV mass 133±36 121±30 0.02
LVEDV/LVmass 1.19±0.32 1.45±0.36 0.0004
LV-scar (% LV mass) 29.6±9.9 23.7±10.0 0.002
% circumference Edema 57.5±14.0 - -
% circumference Scar 30.6±12.6 - -
csh (AVC) mean [%] 10.7±2.6 12.4±2.3 0.002
Tmax mean [ms] 345.7±34.5 390.8±35.4 <0.0001
Tmax SD [ms] 82.2±14.5 79.8±9.5 ns
CURE 0.91±0.05 0.94±0.03 0.004
QRS width (ms) 91.1±8.7 89.2±8.6 ns
Patients measured immediately after acute anterior myocardial infarction
(baseline, n=22) and patients measured again four months later (follow-up,
n=22) different studied parameters are listed: Left ventricular end-diastolic
diameter (LVEDD), left ventricular end-diastolic volume (LVEDV), left ventricular
end-systolic volume (LVESV), left ventricular ejection fraction (LVEF), scar mass,
mean circumferential shortening (csh) over all segments of the left ventricle at
aortic valve closure (AVC), mean and SD of time to maximum csh (Tmax) over
all segments, the circumferential uniformity ratio estimate (CURE). All values
are indicated as mean ± SD.(Figure 5e, r2 = 0.034, p=0.41). Thus, the correlation
between necrosis and regression of dyssynchrony indicates
that LV dyssynchrony persisted in ventricles with smaller
necrosis and improved in ventricles with larger necrosis.
Extent of necrosis in the acute phase was also positively
correlated with an increase in LVEDV (expressed as
ΔLVEDV, Figure 5c) and the extent of necrosis showed
borderline correlation with adverse LV remodelling
(ΔLVEDV/LVmass, Figure 5d). Conversely, the extent of
edema in viable tissue (=salvaged myocardium) did not
correlate with ΔCURE, ΔLVEDV, nor ΔLVEDV/LVmass
(Figure 5 e-g).
Discussion
Mechanisms of dyssynchrony in the acute phase of MI
MR tagging techniques [7] well as other modalities
[25,26] could successfully demonstrate and quantify dys-
synchrony in patients with chronic MIs. In this chronic
stage, scar tissue is the substrate causing dyssynchrony,
most likely by the mechanism of post-systolic shorten-
ing, by which the energy stored in scar tissue during
contraction is released during early diastole [7]. In the
present study, dyssynchrony was also observed in the
setting of acute MI. The amount of hyperintense tissue on
T2-w images correlated with the degree of dyssynchrony
indicating that the underlying substrate for dyssynchrony in
the acute phase is tissue edema, composed of both, viable
edemateous tissue as well as the central necrotic tissue.
The mass of necrotic tissue alone did not correlate signifi-
cantly with the degree of dyssynchrony in the acute phase
of MI. Thus, measurements that consider both, viable and
non-viable edematous tissue best explain intraventricular
LV dyssynchrony in the acute stage. This finding also
suggests that dyssynchrony in the acute phase of MI may
represent at least in part a transitory phenomenon.
Figure 4 Patient example with anterior myocardial infarction (MI). Top row shows edema in the anterior/anteroseptal segments (white
arrows) on T2-weighted (T2) short-axis images (equatorial slice) after acute MI (A) and absent edema at 4 months (B). Bottom row shows
corresponding late gadolinium enhancement (LGE) images with scar formation in the anterior/anteroseptal segments (black arrows) after acute
MI (C) and at 4 months (D).
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healing of acute MI
As was hypothesized, this study could demonstrate a re-
gression of LV dyssynchrony during healing of acute MI
(Table 2). Healing of acute MI was also associated in this
patient population with an increase in LV end-diastolic
and end-systolic volumes, as well as with an increase in
LVEDV/LV mass, a measure of adverse remodelling. At
4 months scar tissue did shrink slightly as demonstrated
earlier [27]. The reduction of dyssynchrony during the
healing period was correlated with the amount of
edematous tissue measured in the acute phase of MI
(Figure 5a). As tissue edema can build up in necrotic as
well as in viable myocardium, further analysis sought to
investigate, which edema component is best predictive
of regression of dyssynchrony. Interestingly, necrosis in
the acute phase of MI inversely correlated with regres-
sion of dyssynchrony, thus indicating, that dyssynchrony
tends to persist in ventricles with smaller necrotic mass,
while dyssynchrony regresses in ventricles with larger
necrosis. This might be explained by the fact, that in
ventricles with very large scars, no sufficient contracting
myocardium is left to cause intraventricular unloading
and thus, post-systolic shortening. Extent of necrosis in
the acute phase was positively correlated with LV dila-
tion during infarct healing and a borderline correlation
was observed for adverse LV remodelling during healing.
Conversely, the edema mass in viable tissue during theacute phase of MI was not predictive for changes in LV
dyssynchrony during healing, thus indicating, that salvaged
myocardium (=edema in viable myocardium) is associated
with dyssynchrony in the acute MI (Figure 2c), while it is
not predictive for regression of dyssynchrony during hea-
ling (Figure 5e).
Implications of the dynamic nature of dyssynchrony
during infarct healing
From a practical point of view the transient nature of the
intraventricular dyssynchrony during the acute phase of MI
may suggest, that the indication for a CRT should be made
with caution during the acute phase and a re-evaluation of
dyssynchrony in the chronic phase is recommended when
remodelling after MI has occurred. Also, in studies aimed
to evaluate responder rates to CRT in patients after AMI,
the stage of LV remodeling and the presence or absence of
edema in the LV myocardium should be taken into account
to enable a comprehensive assessment of the benefit of
CRT in this patient population.
Limitations
The extent of tissue edema was measured in 3 short-axis
levels only, while tagging and LGE data were acquired
over the entire LV. These 3 levels for edema assessment
were chosen as the examination time could not be
expanded deliberately since cooperation in acute MI
patients is often decreasing during long examinations. A
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Figure 5 Predictors of LV remodelling and regression of dyssychrony during infarct healing.
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mass (and not as percentage of LV circumference) might
have yielded tighter correlations with dyssynchrony. As
mentioned in the methods section, for edema quanti-
fication, the extent of hyperintense tissue along the
circumferential midline of each slice was calculated to
avoid problems in discriminating edema tissue with
high signal from high signal of stagnant blood in the
LV cavity. As the edema distribution was typically
transmural, this approach might not have affected
substantially the correlations found between edema
and dyssynchrony. Having these limitations in mind,
we included in this study anterior infarcts only in
order to study rather large infarcts. Thus, the findings
of this study should not be extrapolated to smaller
lateral or inferior infarcts.
Application of the accelerated 3D tagging acqui-
sition technique allows assessing detailed 3D motion
patterns of the entire LV in only three breath-holds.
While the spatial resolution of the final motion parameters
is relatively low (voxel size= 3.9 x 7.7 x 7.7 mm3) with
respect to current imaging standards, regional motion
changes typically occur on a larger scale in the vast majority
of cardiac diseases including coronary artery disease and
left bundle branch block. Hence, the achieved spatial reso-
lution appears sufficient for most applications.
As a consequence of the rather small sample size, we
cannot exclude that some correlations could be missed
(or might be underestimated), however, the positive
correlations found are not affected by this fact and show
the importance of edema in the viable tissue to cause
dyssynchrony. Furthermore, we tried to compensate for
a small sample size by selecting a well defined patient
population and by applying a strictly standardized
imaging protocol.
Conclusions
During infarct healing after revascularisation of acute
anterior MI, intraventricular LV dyssynchrony regresses.
In the acute phase of infarction, LV dyssynchrony is
closely related to the extent of edema, while necrosis
alone does not explain dyssynchrony in the acute phase.
Conversely, regression of dyssynchrony during infarct
healing is best predicted by the extent of necrosis in the
acute phase.
From a practical point of view, the indication for CRT
in post-infarct patients should consider the potential for
improvement of dyssynchrony during infarct healing
which is related to necrosis mass in the acute MI. Also,
in studies assessing responder rates of CRT in ischemic
cardiomyopathy the stage of infarct healing and the
presence or absence of tissue edema should be taken
into account as these factors have been shown to modify
dyssynchrony severity.Abbreviations
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